论文部分内容阅读
1982年第四期本刊介绍了处理心力衰竭新方案的专题讨论方面几篇文章.该期论文探讨各类治疗充血性心力衰竭的药物,重点放在血管扩张剂的应用.同年European Heart Journal也集中讨论新老正性肌力药物的药理与临床应用,各作者从不同的角度提出了较新的观点.由于心力衰竭药物治疗的理论与实践均处于不断变化与不断前进情况,下面几篇报道可认为是目前应予重视的资料,但从近几年发展的趋势来估计,在不久的将来这方面的认识必然将达到较高而更为成熟的阶段.鉴于充血性心力衰竭是一种常见的慢性综合征,往往缺乏根除其基本病变的手段,开展对适合国内医疗条件的疗效高、副作用少的血管扩张剂与非洋地黄类正性肌力药物的研究似有必要.
In 1982, the fourth issue of this article describes the treatment of heart failure new program symposium several articles.This paper discusses various types of treatment of congestive heart failure drugs, with emphasis on the application of vasodilators.In the same year European Heart Journal Focus on discussing the pharmacology and clinical application of new and old inotropic drugs, the authors put forward newer perspectives from different angles.As the theory and practice of heart failure drug treatment are in constant change and continue to progress, the following reports Can be considered as the current should pay attention to the information, but the trend of development in recent years to estimate that in the near future this understanding will inevitably reach a higher and more mature stage. Congestive heart failure is a common Of the chronic syndrome, often lack of means to eradicate its basic lesions, to carry out for the domestic medical conditions of high efficacy, less side effects of vasodilators and non-digitalis positive inotropic drugs research seems necessary.